These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 453450)

  • 41. Dengue in the early febrile phase: viremia and antibody responses.
    Vaughn DW; Green S; Kalayanarooj S; Innis BL; Nimmannitya S; Suntayakorn S; Rothman AL; Ennis FA; Nisalak A
    J Infect Dis; 1997 Aug; 176(2):322-30. PubMed ID: 9237696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Dengue fever and hemorrhagic dengue in infants with a primary infection].
    Martínez E; Guzmán MG; Valdés M; Soler M; Kourí G
    Rev Cubana Med Trop; 1993; 45(2):97-101. PubMed ID: 7984823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity.
    Pichyangkul S; Endy TP; Kalayanarooj S; Nisalak A; Yongvanitchit K; Green S; Rothman AL; Ennis FA; Libraty DH
    J Immunol; 2003 Nov; 171(10):5571-8. PubMed ID: 14607965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype.
    Zivny J; DeFronzo M; Jarry W; Jameson J; Cruz J; Ennis FA; Rothman AL
    J Immunol; 1999 Sep; 163(5):2754-60. PubMed ID: 10453018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitation of T lymphocyte subsets helps to distinguish dengue hemorrhagic fever from classic dengue fever during the acute febrile stage.
    Fadilah SA; Sahrir S; Raymond AA; Cheong SK; Aziz JA; Sivagengei K
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):710-7. PubMed ID: 10928365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunopathological mechanisms in dengue and dengue hemorrhagic fever.
    Green S; Rothman A
    Curr Opin Infect Dis; 2006 Oct; 19(5):429-36. PubMed ID: 16940865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serological and virological studies on patients with dengue hemorrhagic fever (DHF) in Chanthaburi province, Thailand. I. Serological studies on paired sera from DHF patients by neutralization (N), hemagglutination inhibition (HI) and staining tests.
    Okuno Y; Fukunaga T; Srisupaluck S; Kasemsarn P; Dharakul C; Sangkawibha N
    Biken J; 1980 Sep; 23(3):113-21. PubMed ID: 7458894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological changes and recovery in patients with dengue haemorrhagic fever.
    Cornain S; Ikeuchi H; Sumarmo
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):340-5. PubMed ID: 3501614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever.
    Bachal R; Alagarasu K; Singh A; Salunke A; Shah P; Cecilia D
    Arch Virol; 2015 Oct; 160(10):2435-43. PubMed ID: 26175069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
    Guilarde AO; Turchi MD; Siqueira JB; Feres VC; Rocha B; Levi JE; Souza VA; Boas LS; Pannuti CS; Martelli CM
    J Infect Dis; 2008 Mar; 197(6):817-24. PubMed ID: 18269315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever.
    Kliks SC; Nisalak A; Brandt WE; Wahl L; Burke DS
    Am J Trop Med Hyg; 1989 Apr; 40(4):444-51. PubMed ID: 2712199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamics of cellular immune responses in the acute phase of dengue virus infection.
    Yoshida T; Omatsu T; Saito A; Katakai Y; Iwasaki Y; Kurosawa T; Hamano M; Higashino A; Nakamura S; Takasaki T; Yasutomi Y; Kurane I; Akari H
    Arch Virol; 2013 Jun; 158(6):1209-20. PubMed ID: 23381396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production.
    Yang KD; Yeh WT; Yang MY; Chen RF; Shaio MF
    J Med Virol; 2001 Feb; 63(2):150-7. PubMed ID: 11170052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis.
    Myint KS; Endy TP; Mongkolsirichaikul D; Manomuth C; Kalayanarooj S; Vaughn DW; Nisalak A; Green S; Rothman AL; Ennis FA; Libraty DH
    J Infect Dis; 2006 Sep; 194(5):600-7. PubMed ID: 16897658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.
    Noisakran S; Perng GC
    Exp Biol Med (Maywood); 2008 Apr; 233(4):401-8. PubMed ID: 18367628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The first reported outbreak of dengue hemorrhagic fever in Irian Jaya, Indonesia.
    Richards AL; Bagus R; Baso SM; Follows GA; Tan R; Graham RR; Sandjaja B; Corwin AL; Punjabi N
    Am J Trop Med Hyg; 1997 Jul; 57(1):49-55. PubMed ID: 9242317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indices of anti-dengue immunoglobulin G subclasses in adult Mexican patients with febrile and hemorrhagic dengue in the acute phase.
    Posadas-Mondragón A; Aguilar-Faisal JL; Chávez-Negrete A; Guillén-Salomón E; Alcántara-Farfán V; Luna-Rojas L; Ávila-Trejo AM; Del Carmen Pacheco-Yépez J
    Microbiol Immunol; 2017 Oct; 61(10):433-441. PubMed ID: 28881485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Demonstration of dengue antibody complexes on the surface of platelets from patients with dengue hemorrhagic fever.
    Boonpucknavig S; Vuttiviroj O; Bunnag C; Bhamarapravati N; Nimmanitya S
    Am J Trop Med Hyg; 1979 Sep; 28(5):881-4. PubMed ID: 384817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phytohemagglutinin enhancement of dengue-2 virus replication in nonimmune rhesus monkey peripheral blood leukocytes.
    Marchette NJ; Halstead SB
    Infect Immun; 1978 Jan; 19(1):40-5. PubMed ID: 203535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome.
    Nguyen TP; Kikuchi M; Vu TQ; Do QH; Tran TT; Vo DT; Ha MT; Vo VT; Cao TP; Tran VD; Oyama T; Morita K; Yasunami M; Hirayama K
    PLoS Negl Trop Dis; 2008 Oct; 2(10):e304. PubMed ID: 18827882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.